| Financial Year |
March 31 2023 |
| Monetary Funds |
326,287,013.13 |
| Held-for-trading Financial Assets |
1,345,240,312.34 |
| Notes Receivable |
9,426,556.55 |
| Accounts Receivable |
729,764,717.37 |
| Advances to Suppliers |
35,465,523.39 |
| Other Receivables |
55,438,644.60 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
458,995.15 |
| Dividend Receivable |
-- |
| Inventories |
402,264,003.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
70,931,490.81 |
| Total Current Assets |
2,983,122,833.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
402,109,504.20 |
| Investment Properties |
44,450,709.89 |
| Fixed Assetes |
1,167,250,423.57 |
| Under-construction Projects |
403,939,589.55 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
256,029,696.79 |
| R&D expenses |
146,908,312.47 |
| Goodwill |
67,802,743.36 |
| Long-Term Deferred and Prepaid Expenses |
799,910.52 |
| Deferred Income Tax Assets |
9,884,408.36 |
| Other Non-Current Assets |
7,700,658.84 |
| Sub-Total of Non-Current Assets |
3,046,768,816.44 |
| Total Assets |
6,029,891,650.30 |
| Short-Term Loans |
497,583,608.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
117,459,345.50 |
| Accounts Payable |
330,019,669.70 |
| Accounts Received In Advance |
78,767.65 |
| Employee Compensation Payable |
25,695,942.98 |
| Taxes Payable |
29,608,814.65 |
| Interest Payable |
-- |
| Dividend Payable |
764,000.00 |
| Other payables |
107,580,010.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
12,227,995.03 |
| Other Current Liabilities |
5,192,384.85 |
| Sub-Total of Current Liabilities |
1,147,847,165.75 |
| Long-term Loans |
187,821,524.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
57,331,768.94 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
296,430,404.06 |
| Total Liabilities |
1,444,277,569.81 |
| Paid-In Capital(Or Share Stock) |
468,018,786.00 |
| Capital Surplus |
2,204,850,033.13 |
| Surplus Reserve |
195,638,234.69 |
| LESS:Treasury Stock |
41,152,569.55 |
| Undistributed Profits |
1,476,959,616.28 |
| Minority Stockholder's Interest |
281,299,979.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,304,314,100.55 |
| Owner's Equity（Stockholder's Equity） |
4,585,614,080.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,029,891,650.30 |
